FindTrial
Sign In

A prospective validation study of biomarkers for predicting brain metastases from lung cancer

A prospective validation study of biomarkers for predicting brain metastases from lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104343
Enrollment
Unknown
Registered
2025-06-16
Start date
2025-06-23
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Brain metastatic high-risk group:None
Brain metastatic low-risk group:None

Sponsors

West China Hospital,Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Male or female patients aged 18 to 75 years 2.Patients diagnosed with stage I–IV lung cancer within the past 3 months (regardless of histological type) 3.Patients with available pathological tissue specimens obtained through surgery or biopsy 4.No prior history of malignant tumors

Exclusion criteria

Exclusion criteria: 1.Patients with severe psychiatric disorders 2.Pregnant or breastfeeding patients 3.Patients with confirmed brain metastases

Design outcomes

Primary

MeasureTime frame
Cumulative incidence of brain metastasis;—

Secondary

MeasureTime frame
Incidence of brain metastasis;—

Countries

China

Contacts

Public ContactLunxu Liu

West China Hospital,Sichuan University

lunxu_liu@aliyun.com+86 189 8060 1525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026